Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

@article{Clark2006MyopathyIP,
  title={Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?},
  author={D. Clark and J. Strandell},
  journal={European Journal of Clinical Pharmacology},
  year={2006},
  volume={62},
  pages={473-479}
}
ObjectivePolymyositis occurring in patients treated with omeprazole has been signalled as a possible adverse drug reaction (ADR) by the New Zealand Intensive Medicines Monitoring Programme (IMMP) and the WHO Collaborating Centre for International Drug Monitoring: the Uppsala Monitoring Centre (UMC). Polymyositis and other myopathies have also been reported in post-marketing data and in the medical literature in association with proton pump inhibitor (PPI) use. We wished to follow-up these… Expand
76 Citations
MYOPATHY ADVERSE DRUG REACTION ASSOCIATED WITH LANSOPRAZOLE: A CASE REPORT
  • Highly Influenced
  • PDF
Proton Pump Inhibitors
  • 3
Statin-Associated Polymyositis Following Omeprazole Treatment
  • 11
  • PDF
Proton Pump Inhibitors and Risk of Rhabdomyolysis
  • 12
Proton pump inhibitors are not associated with inflammatory myopathies: A case control study
Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction
  • 2
  • PDF
Rhabdomyolysis in an elderly multitreated patient: Multiple drug interactions after statin withdrawal
  • 11
Perils and pitfalls of long-term effects of proton pump inhibitors
  • 90
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 16 REFERENCES
Rhabdomyolysis Causing AV Blockade Due to Possible Atorvastatin, Esomeprazole, and Clarithromycin Interaction
  • 50
  • Highly Influential
Possible Lansoprazole-Induced Eosinophilic Syndrome
  • 14
Rhabdomyolysis associated with omeprazole
  • 18
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.
  • 44
  • Highly Influential
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
  • 561
  • PDF
Quality criteria for early signals of possible adverse drug reactions
  • 103
Signal Generation in the New Zealand Intensive Medicines Monitoring Programme
  • 20
A Bayesian neural network method for adverse drug reaction signal generation
  • 662
Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database
  • 58
...
1
2
...